Home | Publications | Drug Discovery place holder

Drug Discovery Market Research, Intelligence and Forecasts

In this section you will find information products, including market research, covering the Drug Discovery Industry, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.

Stay up-to-date with new products added to this category

place holder place holder place holder place holder place holder place holder

Drug Discovery


Title Sort Publication Date Sort Price Sort
place holder


Outsourcing in Drug Discovery, 3rd Edition

May 2008 £1765
Blood Cancer Drug Discoveries
What the Future Holds

April 2008 £1295
Drug Approval Trends at the FDA and EMEA
Process Improvements, Heightened Scrutiny and Industry Response

April 2008 £1995
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020

January 2008 £1499
Gastrointestinal Drug Discoveries

January 2008 £995
Premium Company Profile: Acambis PLC

November 2007 £265
Combating Generics 2008
Counter-Generics Strategy, Tactics and Execution

October 2007 £3885
Drug Development Opportunities In China
Regulation, Key Players And Initiatives For Domestic And International Markets

September 2007 £1495
Drug Discovery Tools for High-Content Analysis

July 2007 £990
Preparing the Common Technical Document (CTD) for CMC

March 2007 £4950
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Equipment, Technologies and Companies, 2006-2011

January 2007 £815
Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target Space

January 2007 £2675
Current Drug Development Market for Cytokines, Chemokines and Growth Factors

January 2007 £2600
Discovery to IND Filing
2nd Edition

January 2007 £520
Novel Targets in Drug Discovery

November 2006 £2605
CNS Drug Discoveries: Multiple Sclerosis

November 2006 £795
CNS Drug Discoveries: Depression

November 2006 £795
CNS Drug Discoveries: Neurodegenerative Disorders

November 2006 £795
CNS Drug Discoveries: Sleep Disorders

November 2006 £795
CNS Drug Discoveries
What the Future Holds

November 2006 £1995
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues
Revised Edition

October 2006 £2750
Impact of Nano Materials in Drug Delivery & Human Tissue Engineering

October 2006 £2750
Kinases

September 2006 £2750
Managing Toxicology for the Future
Improving Predictive Power Through Integrated Technologies, 2nd Edition

August 2006 £2750
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Quantitative Analysis

August 2006 £2750
Plant-Derived Drugs: Products, Technology, Applications

June 2006 £2410
COPD Drug Discovery
How New Generation Therapies Seek to Target Underlying Disease

June 2006 £2750
Transmembrane Transporters
High Sales, High Potential as Drug Targets

June 2006 £2750
Cardiovascular Drug Discoveries
What the Future Holds

May 2006 £1995
Contract Drug Discovery Industry
Sector Snapshot

March 2006 £250
Drug Repositioning
A market analysis

March 2006 £1095
Cell Therapy Commercialization
Applying Stem Cell and Related Strategies

January 2006 £2750
How to Succeed In Personalized Medicine
by Using Tools and Technologies Which Companies and Technologies are Profiting From a Favorable Regulatory Environment

January 2006 £2750
Guide to Discovery to IND Filing, A

December 2005 £440
Market Opportunities and Challenges for Antibody Arrays and Beads
A Market Research Study

November 2005 £1665
Organic and Medicinal Chemistry in Drug Discovery

November 2005 £2750
RNAi Therapeutics
Challenges in Drug Development and Delivery

November 2005 £1945
Patents in the Postgenomic Era
Proprietary Drug Targets and Therapies

October 2005 £2750
hERG
Technology and Market Analysis

October 2005 £1665
ADME in Children and The Elderly
Clinical Challenges and Opportunities

October 2005 £2750
Combination Therapies
Benefits and Challenges in Drug, Device, and Biologicals Development

October 2005 £1945
Cancer Drug Discoveries
What the Future Holds

August 2005 £1995
Powering Discovery through Target Evaluation
Moving Beyond the Validation Paradigm

August 2005 £1950
Phosphodiesterases
A Drug Target Family with Broad Therapeutic Impact

August 2005 £2750
Model Organisms in Drug Discovery and Development
An Industry Analysis

June 2005 £1665
Event Analysis and Response Service: Cox-2s
Cox-2 Crisis Dents Big Pharma Confidence

June 2005 £6000
Industrialization of Drug Discovery

May 2005 £80
Angiogenesis Modulators
Strategies for Drug Discovery

May 2005 £2750
Rapid Viral Testing

April 2005 £2750
Impact of Nanotechnology in Drug Discovery, The

April 2005 £1665
Impact of Nanotechnology in Drug Discovery; The

March 2005 £1140
Virtual Screening in Drug Discovery

March 2005 £85
Cancer Vaccines Fantasy or Future?

February 2005 £1325
Solving Drug Discovery with Metabolomics and Metabonomics
New Aspects of the "Omic" Revolution

February 2005 £2750
Proteases as Drug Targets

January 2005 £2750
Ethical Issues in Drug Development

January 2005 £220
The Outlook For RNAi
Accelerating drug discovery and the development of RNAi therapeutics

January 2005 £1495
Emerging Drug Discovery Technologies
Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi

January 2005 £1495
Protein- Protein Interactions as Drug Targets
Focusing on Cell Circuitry

January 2005 £1665
RNAi: Broad Application, Expansive Opportunity
2nd Edition

January 2005 £1385
Structure-Guided Drug Design
Rediscovering the Importance of Drug Structure for Drug Discovery

November 2004 £1940
Antibody Therapeutics
Product Development, Market Trends, and Strategic Issues, 2nd Edition

September 2004 £2750
Fluorescent Proteins
Technologies, Applications, and Opportunities for Drug Discovery

August 2004 £1660
Tissue MicroArrays
Emerging Business Opportunities and Applications Driving the Marketplace

August 2004 £2750
Migraine
A market focus

August 2004 £885
Chemical Genomics
Commercial Applications in Drug Discovery and Development

July 2004 £1660
Pharmaceutical Discovery & Development Report

June 2004 £185
Model Animal Systems
Emerging Applications and Commercial Opportunities in Drug Discovery and Development

June 2004 £1946
Ion Channel Drug Discovery
Therapeutic Opportunities & Technology Progress

May 2004 £680
Cell Signalling Pathways
Productive Sources of Pharmaceutical Targets

May 2004 £2750
Peptide Therapeutics
Applications in the Treatment of Human Diseases

April 2004 £1660
Novel Targets in Drug Discovery
A new era in therapy

April 2004 £595
Part 11 and Drug Development
A Q&A Reference Guide (March, 2004)

March 2004 £15
Metabolic Syndrome
New Opportunities in Diagnostics and Therapeutics

February 2004 £2750
Phosphatases
Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets

February 2004 £1660
Systems Biology
Key to Unlocking the Value within the Omics Revolution

January 2004 £1660
Stephens' Detection of New Adverse Drug Reactions
5th Edition

December 2003 £110
Cytokines, Chemokines, and Growth Factors
Key Targets for Immunotherapeutic Development

December 2003 £2750
Lead Optimization
A Reinvention of the Process

November 2003 £1670
Drug Discovery Strategies and Methods

November 2003 £100
Nuclear Receptors
Key Targets for New Pharmaceuticals

November 2003 £2750
Rheumatoid Arthritis: Emerging drug discovery targets
And therapeutic candidates

October 2003 £375
Post-Genomic Biomarkers
Revolutionizing Drug Development and Diagnostics

October 2003 £2750
Asthma Therapeutics
New treatment options and emerging drug discovery targets

April 2003 £330
Burger's Medicinal Chemistry and Drug Discovery
6 Volume Set

March 2003 £1331
Worldwide Drug Discovery R&D
Current Status, Clinical Pipeline, and Analysis

November 2001 £545
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development

August 2001 £815
Drug Discovery Technology
A Combination Of Opportunities

June 2001 £2410
The US Bio-Chip Market for Pharmaceutical Drug Discovery
Technology, Strategic Alliance, Patent Dispute and Market Update - 2002

May 2001 £545
Post Genome Project Era Proteomics R&D Competition

January 2001 £815
Drug Development Programme Management

October 2000 £140
place holder